AbbVie: Is Shire Just Playing Hard to Get?
June 20, 2014 at 14:59 PM EDT
British drug maker Shire (SHPG) turned up its nose at the $46.5 billion offer by U.S. rival AbbVie (ABBV), in the latest move by a U.S. firm to pursue a deal for an overseas company with a lower tax rate. Simply put, Shire says the bid is to low and released ambitious new targets to more [...]
